Marc S. Hermelin

KV Pharmaceutical
4:28 pm
Thu March 10, 2011

Former KV Pharmaceutical CEO pleads guilty to misbranding drugs

The former chairman and CEO of St. Louis-based KV Pharmaceutical Co. has pleaded guilty to two federal charges of misbranding drugs.

The U.S. Attorney's office says that 69-year-old Marc S. Hermelin entered the pleas Thursday. He was sentenced to one month in prison and a $1 million fine and agreed to forfeit $900,000 to the federal government.

KV Pharmaceutical manufactured generic prescription drugs, including a pain relief and opiate drug called morphine sulfate.

Read more